Detail Information of Epigenetic Regulations

General Information of Drug Transporter (DT)
DT ID DTD0227 Transporter Info
Gene Name SLC26A1
Transporter Name Sulfate anion transporter 1
Gene ID
10861
UniProt ID
Q9H2B4
Epigenetic Regulations of This DT (EGR)

Methylation

  Colon cancer

            2 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

 Methylation of SLC26A1 in colon adenocarcinoma [ 1 ]

Location

 5'UTR (cg03256780)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:-1.16E+00 Statistic Test p-value:4.05E-03; Z-score:-9.50E-01

Methylation in Case

 3.24E-01 (Median) Methylation in Control 3.78E-01 (Median)

Studied Phenotype

 Colon cancer[ ICD-11:2B90]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon2

 Methylation of SLC26A1 in colon adenocarcinoma [ 1 ]

Location

 Body (cg09146645)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:-1.06E+00 Statistic Test p-value:5.73E-04; Z-score:-1.44E+00

Methylation in Case

 6.46E-01 (Median) Methylation in Control 6.85E-01 (Median)

Studied Phenotype

 Colon cancer[ ICD-11:2B90]

Experimental Material

 Patient tissue samples

  Hepatocellular carcinoma

            8 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

 Methylation of SLC26A1 in hepatocellular carcinoma [ 2 ]

Location

 5'UTR (cg04897230)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:-1.39E+00 Statistic Test p-value:2.55E-13; Z-score:-3.72E+00

Methylation in Case

 5.56E-01 (Median) Methylation in Control 7.74E-01 (Median)

Studied Phenotype

 Hepatocellular carcinoma[ ICD-11:2C12.02]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon2

 Methylation of SLC26A1 in hepatocellular carcinoma [ 2 ]

Location

 Body (cg27249906)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:-1.56E+00 Statistic Test p-value:2.55E-15; Z-score:-1.34E+01

Methylation in Case

 6.20E-01 (Median) Methylation in Control 9.69E-01 (Median)

Studied Phenotype

 Hepatocellular carcinoma[ ICD-11:2C12.02]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon3

 Methylation of SLC26A1 in hepatocellular carcinoma [ 2 ]

Location

 Body (cg04969220)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:-1.44E+00 Statistic Test p-value:2.11E-09; Z-score:-1.50E+00

Methylation in Case

 3.72E-01 (Median) Methylation in Control 5.35E-01 (Median)

Studied Phenotype

 Hepatocellular carcinoma[ ICD-11:2C12.02]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon4

 Methylation of SLC26A1 in hepatocellular carcinoma [ 2 ]

Location

 Body (cg09359391)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:-1.22E+00 Statistic Test p-value:1.99E-04; Z-score:-9.10E-01

Methylation in Case

 2.25E-01 (Median) Methylation in Control 2.75E-01 (Median)

Studied Phenotype

 Hepatocellular carcinoma[ ICD-11:2C12.02]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon5

 Methylation of SLC26A1 in hepatocellular carcinoma [ 2 ]

Location

 Body (cg11017086)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:-1.37E+00 Statistic Test p-value:3.16E-04; Z-score:-9.64E-01

Methylation in Case

 1.71E-01 (Median) Methylation in Control 2.35E-01 (Median)

Studied Phenotype

 Hepatocellular carcinoma[ ICD-11:2C12.02]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon6

 Methylation of SLC26A1 in hepatocellular carcinoma [ 2 ]

Location

 Body (cg25025399)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:-1.02E+00 Statistic Test p-value:5.85E-04; Z-score:-6.74E-01

Methylation in Case

 8.57E-01 (Median) Methylation in Control 8.73E-01 (Median)

Studied Phenotype

 Hepatocellular carcinoma[ ICD-11:2C12.02]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon7

 Methylation of SLC26A1 in hepatocellular carcinoma [ 2 ]

Location

 3'UTR (cg15090262)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:-1.23E+00 Statistic Test p-value:5.64E-11; Z-score:-6.43E+00

Methylation in Case

 6.10E-01 (Median) Methylation in Control 7.52E-01 (Median)

Studied Phenotype

 Hepatocellular carcinoma[ ICD-11:2C12.02]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon8

 Methylation of SLC26A1 in hepatocellular carcinoma [ 2 ]

Location

 3'UTR (cg07658508)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:1.07E+00 Statistic Test p-value:4.87E-02; Z-score:1.12E+00

Methylation in Case

 8.18E-01 (Median) Methylation in Control 7.67E-01 (Median)

Studied Phenotype

 Hepatocellular carcinoma[ ICD-11:2C12.02]

Experimental Material

 Patient tissue samples

  Pancretic ductal adenocarcinoma

            3 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

 Methylation of SLC26A1 in pancretic ductal adenocarcinoma [ 3 ]

Location

 TSS1500 (cg18194306)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:3.73E+00 Statistic Test p-value:6.07E-07; Z-score:1.57E+00

Methylation in Case

 2.64E-01 (Median) Methylation in Control 7.06E-02 (Median)

Studied Phenotype

 Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon2

 Methylation of SLC26A1 in pancretic ductal adenocarcinoma [ 3 ]

Location

 Body (cg18705155)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:-1.38E+00 Statistic Test p-value:2.05E-05; Z-score:-1.43E+00

Methylation in Case

 4.24E-01 (Median) Methylation in Control 5.85E-01 (Median)

Studied Phenotype

 Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon3

 Methylation of SLC26A1 in pancretic ductal adenocarcinoma [ 3 ]

Location

 Body (cg05399320)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:-1.14E+00 Statistic Test p-value:8.74E-05; Z-score:-1.11E+00

Methylation in Case

 5.51E-01 (Median) Methylation in Control 6.31E-01 (Median)

Studied Phenotype

 Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]

Experimental Material

 Patient tissue samples

  Prostate cancer

            4 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

 Methylation of SLC26A1 in prostate cancer [ 4 ]

Location

 TSS1500 (cg23391214)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:-1.47E+00 Statistic Test p-value:2.99E-02; Z-score:-1.86E+00

Methylation in Case

 1.38E-01 (Median) Methylation in Control 2.02E-01 (Median)

Studied Phenotype

 Prostate cancer[ ICD-11:2C82]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon2

 Methylation of SLC26A1 in prostate cancer [ 4 ]

Location

 TSS1500 (cg18158015)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:1.23E+00 Statistic Test p-value:3.37E-02; Z-score:1.90E+00

Methylation in Case

 8.06E-01 (Median) Methylation in Control 6.55E-01 (Median)

Studied Phenotype

 Prostate cancer[ ICD-11:2C82]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon3

 Methylation of SLC26A1 in prostate cancer [ 4 ]

Location

 Body (cg15992532)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:1.01E+00 Statistic Test p-value:1.05E-02; Z-score:2.84E+00

Methylation in Case

 9.86E-01 (Median) Methylation in Control 9.76E-01 (Median)

Studied Phenotype

 Prostate cancer[ ICD-11:2C82]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon4

 Methylation of SLC26A1 in prostate cancer [ 4 ]

Location

 Body (cg08605458)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:1.08E+00 Statistic Test p-value:1.16E-02; Z-score:2.62E+00

Methylation in Case

 9.10E-01 (Median) Methylation in Control 8.41E-01 (Median)

Studied Phenotype

 Prostate cancer[ ICD-11:2C82]

Experimental Material

 Patient tissue samples

  Atypical teratoid rhabdoid tumor

            6 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

 Methylation of SLC26A1 in atypical teratoid rhabdoid tumor [ 5 ]

Location

 Body (cg04969220)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:-1.07E+00 Statistic Test p-value:1.08E-03; Z-score:-8.77E-01

Methylation in Case

 8.36E-01 (Median) Methylation in Control 8.98E-01 (Median)

Studied Phenotype

 Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon2

 Methylation of SLC26A1 in atypical teratoid rhabdoid tumor [ 5 ]

Location

 Body (cg08848753)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:-1.28E+00 Statistic Test p-value:8.21E-03; Z-score:-8.34E-01

Methylation in Case

 2.20E-01 (Median) Methylation in Control 2.81E-01 (Median)

Studied Phenotype

 Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon3

 Methylation of SLC26A1 in atypical teratoid rhabdoid tumor [ 5 ]

Location

 Body (cg09359391)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:-1.57E+00 Statistic Test p-value:1.03E-02; Z-score:-5.20E-01

Methylation in Case

 1.18E-01 (Median) Methylation in Control 1.85E-01 (Median)

Studied Phenotype

 Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon4

 Methylation of SLC26A1 in atypical teratoid rhabdoid tumor [ 5 ]

Location

 Body (cg10467352)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:-1.03E+00 Statistic Test p-value:1.48E-02; Z-score:-2.82E-01

Methylation in Case

 7.72E-01 (Median) Methylation in Control 7.95E-01 (Median)

Studied Phenotype

 Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon5

 Methylation of SLC26A1 in atypical teratoid rhabdoid tumor [ 5 ]

Location

 Body (cg11017086)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:1.02E+00 Statistic Test p-value:1.99E-02; Z-score:7.81E-02

Methylation in Case

 7.91E-02 (Median) Methylation in Control 7.75E-02 (Median)

Studied Phenotype

 Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon6

 Methylation of SLC26A1 in atypical teratoid rhabdoid tumor [ 5 ]

Location

 3'UTR (cg07658508)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:-1.49E+00 Statistic Test p-value:2.31E-13; Z-score:-2.25E+00

Methylation in Case

 5.84E-01 (Median) Methylation in Control 8.68E-01 (Median)

Studied Phenotype

 Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y]

Experimental Material

 Patient tissue samples

  Bladder cancer

            7 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

 Methylation of SLC26A1 in bladder cancer [ 6 ]

Location

 Body (cg04969220)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:-2.80E+00 Statistic Test p-value:3.54E-13; Z-score:-1.46E+01

Methylation in Case

 2.71E-01 (Median) Methylation in Control 7.59E-01 (Median)

Studied Phenotype

 Bladder cancer[ ICD-11:2C94]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon2

 Methylation of SLC26A1 in bladder cancer [ 6 ]

Location

 Body (cg09359391)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:-2.49E+00 Statistic Test p-value:1.45E-11; Z-score:-1.13E+01

Methylation in Case

 1.81E-01 (Median) Methylation in Control 4.51E-01 (Median)

Studied Phenotype

 Bladder cancer[ ICD-11:2C94]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon3

 Methylation of SLC26A1 in bladder cancer [ 6 ]

Location

 Body (cg11017086)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:-2.70E+00 Statistic Test p-value:2.75E-11; Z-score:-1.09E+01

Methylation in Case

 1.56E-01 (Median) Methylation in Control 4.21E-01 (Median)

Studied Phenotype

 Bladder cancer[ ICD-11:2C94]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon4

 Methylation of SLC26A1 in bladder cancer [ 6 ]

Location

 Body (cg23958868)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:-2.22E+00 Statistic Test p-value:4.08E-08; Z-score:-6.87E+00

Methylation in Case

 1.77E-01 (Median) Methylation in Control 3.93E-01 (Median)

Studied Phenotype

 Bladder cancer[ ICD-11:2C94]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon5

 Methylation of SLC26A1 in bladder cancer [ 6 ]

Location

 Body (cg08848753)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:-1.03E+00 Statistic Test p-value:1.77E-04; Z-score:-5.07E+00

Methylation in Case

 9.27E-01 (Median) Methylation in Control 9.51E-01 (Median)

Studied Phenotype

 Bladder cancer[ ICD-11:2C94]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon6

 Methylation of SLC26A1 in bladder cancer [ 6 ]

Location

 Body (cg16868776)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:-1.08E+00 Statistic Test p-value:2.27E-03; Z-score:-2.43E+00

Methylation in Case

 7.63E-01 (Median) Methylation in Control 8.26E-01 (Median)

Studied Phenotype

 Bladder cancer[ ICD-11:2C94]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon7

 Methylation of SLC26A1 in bladder cancer [ 6 ]

Location

 Body (cg25025399)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:-1.01E+00 Statistic Test p-value:4.48E-02; Z-score:-2.88E-01

Methylation in Case

 8.17E-01 (Median) Methylation in Control 8.25E-01 (Median)

Studied Phenotype

 Bladder cancer[ ICD-11:2C94]

Experimental Material

 Patient tissue samples

  Breast cancer

            7 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

 Methylation of SLC26A1 in breast cancer [ 7 ]

Location

 Body (cg09359391)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:-1.39E+00 Statistic Test p-value:6.13E-14; Z-score:-2.40E+00

Methylation in Case

 4.08E-01 (Median) Methylation in Control 5.67E-01 (Median)

Studied Phenotype

 Breast cancer[ ICD-11:2C60-2C6Z]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon2

 Methylation of SLC26A1 in breast cancer [ 7 ]

Location

 Body (cg23958868)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:-1.34E+00 Statistic Test p-value:1.98E-13; Z-score:-2.37E+00

Methylation in Case

 4.52E-01 (Median) Methylation in Control 6.07E-01 (Median)

Studied Phenotype

 Breast cancer[ ICD-11:2C60-2C6Z]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon3

 Methylation of SLC26A1 in breast cancer [ 7 ]

Location

 Body (cg11017086)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:-1.59E+00 Statistic Test p-value:1.08E-09; Z-score:-1.80E+00

Methylation in Case

 3.35E-01 (Median) Methylation in Control 5.34E-01 (Median)

Studied Phenotype

 Breast cancer[ ICD-11:2C60-2C6Z]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon4

 Methylation of SLC26A1 in breast cancer [ 7 ]

Location

 Body (cg04969220)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:-1.16E+00 Statistic Test p-value:2.63E-09; Z-score:-2.01E+00

Methylation in Case

 6.48E-01 (Median) Methylation in Control 7.49E-01 (Median)

Studied Phenotype

 Breast cancer[ ICD-11:2C60-2C6Z]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon5

 Methylation of SLC26A1 in breast cancer [ 7 ]

Location

 Body (cg08848753)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:-1.02E+00 Statistic Test p-value:8.91E-05; Z-score:-1.17E+00

Methylation in Case

 9.29E-01 (Median) Methylation in Control 9.50E-01 (Median)

Studied Phenotype

 Breast cancer[ ICD-11:2C60-2C6Z]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon6

 Methylation of SLC26A1 in breast cancer [ 7 ]

Location

 Body (cg16868776)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:-1.12E+00 Statistic Test p-value:5.75E-04; Z-score:-8.22E-01

Methylation in Case

 7.40E-01 (Median) Methylation in Control 8.30E-01 (Median)

Studied Phenotype

 Breast cancer[ ICD-11:2C60-2C6Z]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon7

 Methylation of SLC26A1 in breast cancer [ 7 ]

Location

 Body (cg25025399)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:-1.04E+00 Statistic Test p-value:1.25E-03; Z-score:-9.79E-01

Methylation in Case

 8.29E-01 (Median) Methylation in Control 8.61E-01 (Median)

Studied Phenotype

 Breast cancer[ ICD-11:2C60-2C6Z]

Experimental Material

 Patient tissue samples

  Renal cell carcinoma

            2 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

 Methylation of SLC26A1 in clear cell renal cell carcinoma [ 8 ]

Location

 Body (cg04969220)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:-1.04E+00 Statistic Test p-value:3.48E-03; Z-score:-6.43E-01

Methylation in Case

 7.83E-01 (Median) Methylation in Control 8.18E-01 (Median)

Studied Phenotype

 Renal cell carcinoma[ ICD-11:2C90]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon2

 Methylation of SLC26A1 in clear cell renal cell carcinoma [ 8 ]

Location

 Body (cg11017086)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:-1.06E+00 Statistic Test p-value:2.75E-02; Z-score:-6.61E-01

Methylation in Case

 3.83E-01 (Median) Methylation in Control 4.07E-01 (Median)

Studied Phenotype

 Renal cell carcinoma[ ICD-11:2C90]

Experimental Material

 Patient tissue samples

  Colorectal cancer

            5 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

 Methylation of SLC26A1 in colorectal cancer [ 9 ]

Location

 Body (cg25025399)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:-1.03E+00 Statistic Test p-value:2.25E-06; Z-score:-1.85E+00

Methylation in Case

 8.98E-01 (Median) Methylation in Control 9.21E-01 (Median)

Studied Phenotype

 Colorectal cancer[ ICD-11:2B91]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon2

 Methylation of SLC26A1 in colorectal cancer [ 9 ]

Location

 Body (cg18168751)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:-1.01E+00 Statistic Test p-value:6.62E-05; Z-score:-6.97E-01

Methylation in Case

 9.63E-01 (Median) Methylation in Control 9.68E-01 (Median)

Studied Phenotype

 Colorectal cancer[ ICD-11:2B91]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon3

 Methylation of SLC26A1 in colorectal cancer [ 9 ]

Location

 Body (cg08848753)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:-1.00E+00 Statistic Test p-value:6.59E-04; Z-score:-7.05E-01

Methylation in Case

 9.70E-01 (Median) Methylation in Control 9.73E-01 (Median)

Studied Phenotype

 Colorectal cancer[ ICD-11:2B91]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon4

 Methylation of SLC26A1 in colorectal cancer [ 9 ]

Location

 Body (cg23958868)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:-1.18E+00 Statistic Test p-value:1.43E-03; Z-score:-1.16E+00

Methylation in Case

 4.95E-01 (Median) Methylation in Control 5.86E-01 (Median)

Studied Phenotype

 Colorectal cancer[ ICD-11:2B91]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon5

 Methylation of SLC26A1 in colorectal cancer [ 9 ]

Location

 3'UTR (cg07658508)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:-1.07E+00 Statistic Test p-value:2.43E-05; Z-score:-9.14E-01

Methylation in Case

 8.31E-01 (Median) Methylation in Control 8.86E-01 (Median)

Studied Phenotype

 Colorectal cancer[ ICD-11:2B91]

Experimental Material

 Patient tissue samples

  HIV infection

            8 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

 Methylation of SLC26A1 in HIV infection [ 10 ]

Location

 Body (cg09359391)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:1.20E+00 Statistic Test p-value:6.85E-05; Z-score:1.53E+00

Methylation in Case

 4.28E-01 (Median) Methylation in Control 3.57E-01 (Median)

Studied Phenotype

 HIV infection[ ICD-11:1C62.Z]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon2

 Methylation of SLC26A1 in HIV infection [ 10 ]

Location

 Body (cg11017086)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:1.31E+00 Statistic Test p-value:1.20E-04; Z-score:1.18E+00

Methylation in Case

 3.14E-01 (Median) Methylation in Control 2.39E-01 (Median)

Studied Phenotype

 HIV infection[ ICD-11:1C62.Z]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon3

 Methylation of SLC26A1 in HIV infection [ 10 ]

Location

 Body (cg04969220)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:1.02E+00 Statistic Test p-value:4.03E-03; Z-score:5.84E-01

Methylation in Case

 8.75E-01 (Median) Methylation in Control 8.54E-01 (Median)

Studied Phenotype

 HIV infection[ ICD-11:1C62.Z]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon4

 Methylation of SLC26A1 in HIV infection [ 10 ]

Location

 Body (cg23958868)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:1.11E+00 Statistic Test p-value:5.99E-03; Z-score:5.19E-01

Methylation in Case

 4.37E-01 (Median) Methylation in Control 3.95E-01 (Median)

Studied Phenotype

 HIV infection[ ICD-11:1C62.Z]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon5

 Methylation of SLC26A1 in HIV infection [ 10 ]

Location

 Body (cg16868776)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:-1.03E+00 Statistic Test p-value:1.04E-02; Z-score:-5.85E-01

Methylation in Case

 8.03E-01 (Median) Methylation in Control 8.25E-01 (Median)

Studied Phenotype

 HIV infection[ ICD-11:1C62.Z]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon6

 Methylation of SLC26A1 in HIV infection [ 10 ]

Location

 Body (cg25025399)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:-1.01E+00 Statistic Test p-value:2.88E-02; Z-score:-6.73E-01

Methylation in Case

 9.19E-01 (Median) Methylation in Control 9.32E-01 (Median)

Studied Phenotype

 HIV infection[ ICD-11:1C62.Z]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon7

 Methylation of SLC26A1 in HIV infection [ 10 ]

Location

 Body (cg21743826)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:-1.07E+00 Statistic Test p-value:4.90E-02; Z-score:-5.47E-01

Methylation in Case

 7.63E-01 (Median) Methylation in Control 8.20E-01 (Median)

Studied Phenotype

 HIV infection[ ICD-11:1C62.Z]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon8

 Methylation of SLC26A1 in HIV infection [ 10 ]

Location

 3'UTR (cg07658508)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:1.71E+00 Statistic Test p-value:4.72E-10; Z-score:3.43E+00

Methylation in Case

 7.78E-01 (Median) Methylation in Control 4.54E-01 (Median)

Studied Phenotype

 HIV infection[ ICD-11:1C62.Z]

Experimental Material

 Patient tissue samples

  Lung adenocarcinoma

            3 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

 Methylation of SLC26A1 in lung adenocarcinoma [ 11 ]

Location

 Body (cg11017086)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:-1.22E+00 Statistic Test p-value:9.70E-03; Z-score:-2.99E+00

Methylation in Case

 4.27E-01 (Median) Methylation in Control 5.20E-01 (Median)

Studied Phenotype

 Lung adenocarcinoma[ ICD-11:2C25.0]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon2

 Methylation of SLC26A1 in lung adenocarcinoma [ 11 ]

Location

 Body (cg08848753)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:-1.01E+00 Statistic Test p-value:3.46E-02; Z-score:-1.78E+00

Methylation in Case

 9.50E-01 (Median) Methylation in Control 9.62E-01 (Median)

Studied Phenotype

 Lung adenocarcinoma[ ICD-11:2C25.0]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon3

 Methylation of SLC26A1 in lung adenocarcinoma [ 11 ]

Location

 3'UTR (cg07658508)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:1.12E+00 Statistic Test p-value:1.82E-02; Z-score:1.42E+00

Methylation in Case

 7.63E-01 (Median) Methylation in Control 6.82E-01 (Median)

Studied Phenotype

 Lung adenocarcinoma[ ICD-11:2C25.0]

Experimental Material

 Patient tissue samples

  Papillary thyroid cancer

            5 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

 Methylation of SLC26A1 in papillary thyroid cancer [ 12 ]

Location

 Body (cg11017086)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:-1.20E+00 Statistic Test p-value:3.90E-03; Z-score:-1.09E+00

Methylation in Case

 2.90E-01 (Median) Methylation in Control 3.47E-01 (Median)

Studied Phenotype

 Papillary thyroid cancer[ ICD-11:2D10.1]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon2

 Methylation of SLC26A1 in papillary thyroid cancer [ 12 ]

Location

 Body (cg10467352)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:-1.01E+00 Statistic Test p-value:4.19E-03; Z-score:-4.37E-01

Methylation in Case

 9.38E-01 (Median) Methylation in Control 9.44E-01 (Median)

Studied Phenotype

 Papillary thyroid cancer[ ICD-11:2D10.1]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon3

 Methylation of SLC26A1 in papillary thyroid cancer [ 12 ]

Location

 Body (cg23958868)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:-1.17E+00 Statistic Test p-value:6.48E-03; Z-score:-9.86E-01

Methylation in Case

 3.04E-01 (Median) Methylation in Control 3.56E-01 (Median)

Studied Phenotype

 Papillary thyroid cancer[ ICD-11:2D10.1]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon4

 Methylation of SLC26A1 in papillary thyroid cancer [ 12 ]

Location

 Body (cg09359391)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:-1.10E+00 Statistic Test p-value:1.86E-02; Z-score:-6.94E-01

Methylation in Case

 3.65E-01 (Median) Methylation in Control 4.02E-01 (Median)

Studied Phenotype

 Papillary thyroid cancer[ ICD-11:2D10.1]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon5

 Methylation of SLC26A1 in papillary thyroid cancer [ 12 ]

Location

 Body (cg08848753)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:-1.00E+00 Statistic Test p-value:4.09E-02; Z-score:-4.63E-01

Methylation in Case

 9.31E-01 (Median) Methylation in Control 9.34E-01 (Median)

Studied Phenotype

 Papillary thyroid cancer[ ICD-11:2D10.1]

Experimental Material

 Patient tissue samples

  Panic disorder

            1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

 Methylation of SLC26A1 in panic disorder [ 13 ]

Location

 3'UTR (cg07658508)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change:-4.06E-01 Statistic Test p-value:1.21E-03; Z-score:-4.30E-01

Methylation in Case

 -5.63E-01 (Median) Methylation in Control -2.29E-01 (Median)

Studied Phenotype

 Panic disorder[ ICD-11:6B01]

Experimental Material

 Patient tissue samples
References
1 Genome-scale analysis of DNA methylation in colorectal cancer using Infinium HumanMethylation450 BeadChips. Epigenetics. 2013 Sep;8(9):921-34.
2 Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips. Epigenetics. 2013 Jan;8(1):34-43.
3 Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling. Int J Cancer. 2014 Sep 1;135(5):1110-8.
4 Reducing the risk of false discovery enabling identification of biologically significant genome-wide methylation status using the HumanMethylation450 array. BMC Genomics. 2014 Jan 22;15:51.
5 Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes. Cancer Cell. 2016 Mar 14;29(3):379-393.
6 DNA Methylation Dynamics in Urological Tumors.
7 Genome-wide Scan for Methylation Profiles in Breast Cancer
8 A CpG-methylation-based assay to predict survival in clear cell renal cell carcinoma. Nat Commun. 2015 Oct 30;6:8699.
9 Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer. Gastroenterology. 2014 Aug;147(2):418-29.e8.
10 HIV-1 Infection Accelerates Age According to the Epigenetic Clock. J Infect Dis. 2015 Nov 15;212(10):1563-73.
11 DNA methylation analysis of lung adenocarcinoma and adjacent non-tumor tissues
12 Prognostic Classifier Based on Genome-Wide DNA Methylation Profiling in Well-Differentiated Thyroid Tumors. J Clin Endocrinol Metab. 2017 Nov 1;102(11):4089-4099.
13 DNA Methylation signatures in panic disorder. Transl Psychiatry. 2017 Dec 18;7(12):1287.

If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.